Clinical Trials Browser

regadenoson × Clear all

NCT03505736 2026-01-29

Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8

NCT03971734 2023-10-06

Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas

Phase 1 Terminated

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma